These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 37522667)

  • 1. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI.
    Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
    Khedr EM; Abdelwarith A; Moussa G; Saber M
    J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy.
    Jantasri S; Tiamkao S; Sawanyawisuth K
    Clin Neurol Neurosurg; 2020 Nov; 198():106206. PubMed ID: 32932029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
    Bala F; Singh N; Buck B; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Appireddy R; Moreau F; Phillips S; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Williams H; Field TS; Manosalva Alzate A; Siddiqui M; Zafar A; Imoukhoude O; Hunter G; Alhabli I; Benali F; Horn M; Hill MD; Shamy M; Sajobi TT; Swartz RH; Menon BK; Almekhlafi M
    JAMA Neurol; 2023 Aug; 80(8):824-832. PubMed ID: 37428494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study.
    Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y
    J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
    Pan SM; Liu JF; Liu M; Shen S; Li HJ; Dai LH; Chen XJ
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke.
    Kaburagi K; Shimizu T; Hagiwara Y; Fukano T; Shibata S; Hoshino M; Sasaki N; Akiyama H; Hasegawa Y; Yamano Y
    J Med Ultrason (2001); 2023 Jan; 50(1):103-109. PubMed ID: 36463366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Receiving Thrombectomy: Standard or Low Dose Therapy?
    Lin CH; Liu CH; Wang AY; Wu YM; Chen CC; Tsai YH; Chang TY; Huang KL; Wu HC; Lee TH; Chang YJ; Lin CM; Cheng CK; Chang CH
    Curr Neurovasc Res; 2018; 15(3):204-210. PubMed ID: 30014803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.
    Teekaput C; Thiankhaw K; Tanprawate S; Teekaput K; Chai-Adisaksopha C
    PLoS One; 2022; 17(8):e0272257. PubMed ID: 35913922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis.
    Karaszewski B; Wyszomirski A; Jabłoński B; Werring DJ; Tomaka D
    Transl Stroke Res; 2021 Jun; 12(3):406-415. PubMed ID: 33641037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis.
    Wu H; Liu Y; Miao G; Ge J; You S; Zhang X; Liu H; Zhou Y; Lu T; Cao Y; Shi J
    Postgrad Med J; 2023 Jun; 99(1172):588-594. PubMed ID: 37319158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.